Neuroblastoma patient-derived orthotopic xenografts retain metastatic patterns and geno- and phenotypes of patient tumours

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages E252-E261

  Braekeveldt, Noémie ^a   Wigerup, Caroline ^a   Gisselsson, David ^a,b   Mohlin, Sofie ^a   Merselius, My ^a   Beckman, Siv ^a   Jonson, Tord ^a   Börjesson, Anna ^c   Backman, Torbjörn ^c   Tadeo, Irene ^d   Berbegall, Ana P ^d,e   Öra, Ingrid ^f   Navarro, Samuel ^e   Noguera, Rosa ^e   Påhlman, Sven ^a   Bexell, Daniel ^a  

^a LUND UNIVERSITY   (Sweden)

^b University and Regional Laboratories   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f LUND UNIVERSITY   (Sweden)

Author keywords

Bone marrow metastasis; MYCN; Neuroblastoma; Neuroblastoma metastasis; Orthotopic xenograft; Patient derived xenograft

Indexed keywords

CHROMOGRANIN A; FLUORODEOXYGLUCOSE; KI 67 ANTIGEN; NERVE CELL ADHESION MOLECULE; SYNAPTOPHYSIN; TYROSINE 3 MONOOXYGENASE; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHGA GENE; CHILD; CHROMOSOME ABERRATION; CONTROLLED STUDY; CRYOPRESERVATION; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; MYCN GENE; NEUROBLASTOMA; NONHUMAN; NPY GENE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; PATIENT DERIVED ORTHOTOPIC XENOGRAFT; PHENOTYPE; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; SYP GENE; TH GENE; TUMOR GROWTH; TUMOR XENOGRAFT; ANIMAL; BONE MARROW CANCER; ENZYME IMMUNOASSAY; GENETICS; INFANT; LIVER TUMOR; LUNG TUMOR; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; TUMOR CELL CULTURE; WESTERN BLOTTING; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; BONE MARROW NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENOTYPE; HETEROGRAFTS; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MICE; NEUROBLASTOMA; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 84918532694     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29217     Document Type: Article

References (28)

1. Cheung NK, Dyer MA. Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 2013;13:397-411.
2. Maris JM, Hogarty MD, Bagatell R, et al. Neuroblastoma. Lancet 2007;369:2106-20.
3. Coulon A, Flahaut M, Muhlethaler-Mottet A, et al. Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model. Neoplasia 2011;13:991-1004.
4. Hansford LM, McKee AE, Zhang L, et al. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumorinitiating cell. Cancer Res 2007;67:11234-43.
5. Khanna C, Jaboin JJ, Drakos E, et al. Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis. In Vivo 2002;16:77-85.
6. Patterson DM, Shohet JM, Kim ES. Preclinical models of pediatric solid tumours (neuroblastoma) and their use in drug discovery. Curr Protoc Pharmacol 2011; Chapter 14: Unit 147.
7. Teitz T, Stanke JJ, Federico S, et al. Preclinical models for neuroblastoma: establishing a baseline for treatment. PLoS One 2011;6:e19133.
8. Bate-Eya LT, Ebus ME, Koster J, et al. Newlyderived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours. Eur J Cancer 2014;50:628-37.
9. Joseph JM, Gross N, Lassau N, et al. In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts. Int J Cancer 2005;113:881-90.
10. Tentler JJ, Tan AC, Weekes CD, et al. Patientderived tumour xenografts as models for oncology drug development. Nat Rev Clin Oncol 2012;9:338-50.
11. Bell E, Chen L, Viprey VF, et al. Meeting report: 3rd Neuroblastoma Research Symposium, Liverpool, 6-7th November, 2013. Pediatr Blood Cancer 2014.
12. Siolas D, Hannon GJ. Patient-derived tumor xenografts: transforming clinical samples into mouse models. Cancer Res 2013;73:5315-9.
13. Houghton PJ, Morton CL, Tucker C, et al. The pediatric preclinical testing program: description of models and early testing results. Pediatr Blood Cancer 2007;49:928-40.
14. Jamil S, Hultman I, Cedervall J, et al. Tropism of the in situ growth from biopsies of childhood neuroectodermal tumours following transplantation into experimental teratoma. Int J Cancer 2014;134:1630-7.
15. Tadeo I, Piqueras M, Montaner D, et al. Quantitative modeling of clinical, cellular, and extracellular matrix variables suggest prognostic indicators in cancer: a model in neuroblastoma. Pediatr Res 2014;75:302-14.
16. Mohlin S, Pietras A, Wigerup C, et al. Tumorinitiating cells in childhood neuroblastoma-letter. Cancer Res 2012;72:821-2; author reply 3.
17. Carr J, Bown NP, Case MC, et al. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays. Cancer Genet Cytogenet 2007;172:127-38.
18. Kryh H, Caren H, Erichsen J, et al. Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumours. BMC Genomics 2011;12:443.
19. Romansky S, Landing B. Metastatic patterns in childhood tumours. In: Weiss L, Gilbert H, eds. Pulmonary metastasis. Boston: Medical Publications, 1978. 114-7.
20. Linnebacher M, Maletzki C, Ostwald C, et al. Cryopreservation of human colorectal carcinomas prior to xenografting. BMC Cancer 2010;10:362.
21. Sorio C, Bonora A, Orlandini S, et al. Successful xenografting of cryopreserved primary pancreatic cancers. Virchows Arch 2001;438:154-8.
22. Heukamp LC, Thor T, Schramm A, et al. Targeted expression of mutated ALK induces neuroblastoma in transgenic mice. Sci Transl Med 2012;4:141ra91.
23. Teitz T, Inoue M, Valentine MB, et al. Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis. Cancer Res 2013;73:4086-97.
24. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16.
25. Westermark UK, Wilhelm M, Frenzel A, et al. The MYCN oncogene and differentiation in neuroblastoma. Semin Cancer Biol 2011;21:256-66.
26. Zhu S, Lee JS, Guo F, et al. Activated ALK collaborates with MYCN in neuroblastoma pathogenesis. Cancer Cell 2012;21:362-73.
27. Berry T, Luther W, Bhatnagar N, et al. The ALK (F1174L) mutation potentiates the oncogenic activity of MYCN in neuroblastoma. Cancer Cell 2012;22:117-30.
28. Weiss WA, Aldape K, Mohapatra G, et al. Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 1997;16:2985-95.